wire - news in brief
« BACK
Health - Campus - 10.05.2021
Health - Event - 10.05.2021
Environment - Health - 10.05.2021
Health - Social Sciences - 07.05.2021
Pharmacology - Health - 05.05.2021
Health - 03.05.2021
Pharmacology - Health - 03.05.2021
Pharmacology - Health - 01.05.2021
Health - Psychology - 30.04.2021
Pharmacology - Health - 28.04.2021
Health - Life Sciences - 28.04.2021 
Awakening "ghosts" in patients with Parkinson's
Scientists are developing a completely new "brain stress test" for evaluating the mental status of patients with Parkinson's disease, the second most prevalent neurodegenerative disease worldwide. It involves awakening the "ghosts" hidden in specific networks of the brain to predict the onset of hallucinations.
Social Sciences - Health - 27.04.2021 
Jeunes3 Programme Comes to a Close
The JeuneS3 (Santé, Sécurité, Sexualité) programme, which focused on improving adolescent and youth sexual and reproductive health in four Francophone African countries, has come to a close after four successful years.
Pharmacology - Health - 27.04.2021
Pharmacology - Health - 27.04.2021
Health - Psychology - 26.04.2021 
Seroprevalance has increased to 21% in the Basel region
In the cantons of Basel-Stadt and Basel-Landschaft, antibodies against SARS-CoV-2 have been detected in approximately 21% of the adult population. Therefore, seroprevalance has markedly increased since autumn of last year. Furthermore, the COVCO-Basel study by the Swiss Tropical and Public Health Institute (Swiss TPH) is now publishing preliminary results regarding the effects that the pandemic and the measures implemented to contain it are having on the well-being and lifestyles of the population for the first time.
Environment - Health - 26.04.2021
Campus - Health - 26.04.2021
Health - 26.04.2021
Health - Psychology - 26.04.2021 
La séroprévalence a augmenté à 21% dans la région de Bâle
In the cantons of Basel-Stadt and Basel-Landschaft, antibodies against SARS-CoV-2 have been detected in approximately 21% of the adult population.
Health - 23.04.2021 
New Modelling Project Launched to Support National Malaria Control Programmes
Over the past two decades, substantial progress has been made in reducing the global burden of malaria through vector control interventions and improved access to diagnosis and treatment.
Pharmacology - Health - 23.04.2021
Health - 23.04.2021
Health - 23.04.2021
Health - Life Sciences - 23.04.2021
Life Sciences - Health - 22.04.2021
Pharmacology - Health - 22.04.2021
Health - Economics / Business - 22.04.2021
Health - Life Sciences - 20.04.2021 
Bioprinted mini pancreas will help in the fight against diabetes
EPFL spin-off Readily3D has developed a novel system that can print biological tissue in just 30 seconds.
Pharmacology - Health - 16.04.2021
Health - Pharmacology - 15.04.2021
Pharmacology - Health - 15.04.2021
Health - 14.04.2021
Campus - Health - 13.04.2021 
What will endure?
The end of the pandemic is still not in sight, but we have every reason to be hopeful. How has the first year of living with the virus changed ETH? And what will endure after the crisis ends? I only briefly experienced what ETH was like before the pandemic.
Environment - Health - 12.04.2021
Health - 12.04.2021
Health - 06.04.2021
Health - Environment - 01.04.2021 
Pollen Season in Switzerland Earlier and More Intense Due to Climate Change
Bad news for allergy sufferers: The rising temperatures over the past three decades have impacted the onset, duration and intensity of the pollen season in Switzerland. These are the results of a study by the Swiss Tropical and Public Health Institute (Swiss TPH) in collaboration with the Federal Office of Meteorology and Climatology (MeteoSwiss).
Health - Life Sciences - 31.03.2021 
Why SARS-CoV-2 replicates better in the upper respiratory tract
A team of researchers from the Institute for Infectious Diseases (IFIK) at the University of Bern and the Federal Institute of Virology and Immunology (IVI) have assessed virus growth and activation
Health - Pharmacology - 31.03.2021
Health - Pharmacology - 30.03.2021
Health - Pharmacology - 30.03.2021
Pharmacology - Health - 30.03.2021
Health - 29.03.2021
Health - Economics / Business - 29.03.2021 
Research and know-how for SMEs
Making more targeted use of digital technologies, advancing industrial projects with the new OST Ostschweizer Fachhochschule (Eastern Switzerland University of Applied Sciences) and building a bridge to basic research thanks to Empa in St. Gallen.
Health - Pharmacology - 25.03.2021
Pharmacology - Health - 24.03.2021 
Clinical Trial of Multi Drug-Resistant TB Treatment Ends Enrolment Early, Offering Hope for TB Patients
A trial aiming to find a better treatment for multidrug-resistant tuberculosis (MDR-TB) has stopped enrolling patients early after its independent data safety and monitoring board indicated that the regimen being studied is superior to current care, and that more patient data was extremely unlikely to change the trial's outcome.
Pharmacology - Health - 23.03.2021
Life Sciences - Health - 22.03.2021 
Shaking the Foundations of Life
Evolution never stops - and disruptions can speed up the procees. Now ETH researchers are delving deeper into the secrets of evolutionary change.
Health - Politics - 22.03.2021
Health - 22.03.2021
Health
Results 1 - 50 of 2230.
2020 Annual Report published
With research, teaching and consulting on all aspects of water, Eawag is committed to a sustainable future - in Switzerland and worldwide. This is illustrated by the diverse and exciting projects that we present in our Annual Report. Our new Annual Report shows what the aquatic research institute Eawag has experienced and achieved in this challenging year of 2020.
With research, teaching and consulting on all aspects of water, Eawag is committed to a sustainable future - in Switzerland and worldwide. This is illustrated by the diverse and exciting projects that we present in our Annual Report. Our new Annual Report shows what the aquatic research institute Eawag has experienced and achieved in this challenging year of 2020.
Sandoz confirms late-stage clinical development plans for proposed biosimilar aflibercept, a key ophthalmology medicine
Sandoz to begin enrolling patients with neovascular age-related macular degeneration in MYLIGHT Phase lll confirmatory efficacy and safety study 1 Neovascular age-related macular degeneration account
Sandoz to begin enrolling patients with neovascular age-related macular degeneration in MYLIGHT Phase lll confirmatory efficacy and safety study 1 Neovascular age-related macular degeneration account
Vaccination - personal values and group dynamics are decisive
How do you get more people to have vaccinations? Gudela Grote firmly believes that it's worth looking at team dynamics.
How do you get more people to have vaccinations? Gudela Grote firmly believes that it's worth looking at team dynamics.
Scientists are developing a completely new "brain stress test" for evaluating the mental status of patients with Parkinson's disease, the second most prevalent neurodegenerative disease worldwide. It involves awakening the "ghosts" hidden in specific networks of the brain to predict the onset of hallucinations.
The JeuneS3 (Santé, Sécurité, Sexualité) programme, which focused on improving adolescent and youth sexual and reproductive health in four Francophone African countries, has come to a close after four successful years.
ANTICOV: Largest Clinical Trial in Africa to Test New Drug Combination
The need for effective COVID-19 treatments remains particularly acute, especially in sub-Saharan Africa where access to vaccines is still extremely limited.
The need for effective COVID-19 treatments remains particularly acute, especially in sub-Saharan Africa where access to vaccines is still extremely limited.
In the cantons of Basel-Stadt and Basel-Landschaft, antibodies against SARS-CoV-2 have been detected in approximately 21% of the adult population. Therefore, seroprevalance has markedly increased since autumn of last year. Furthermore, the COVCO-Basel study by the Swiss Tropical and Public Health Institute (Swiss TPH) is now publishing preliminary results regarding the effects that the pandemic and the measures implemented to contain it are having on the well-being and lifestyles of the population for the first time.
In the cantons of Basel-Stadt and Basel-Landschaft, antibodies against SARS-CoV-2 have been detected in approximately 21% of the adult population.
Over the past two decades, substantial progress has been made in reducing the global burden of malaria through vector control interventions and improved access to diagnosis and treatment.
World Laboratory Day 2021: Talent for top-level cancer research
In conjunction with World Laboratory Day 2021, Inselspital, Bern University Hospital and the University of Bern interview SNF Professor Dr. Georgia Konstantinidou about her work and recent findings to provide insight into a research laboratory. Cancer claims more than 42 000 lives in Switzerland every year.
In conjunction with World Laboratory Day 2021, Inselspital, Bern University Hospital and the University of Bern interview SNF Professor Dr. Georgia Konstantinidou about her work and recent findings to provide insight into a research laboratory. Cancer claims more than 42 000 lives in Switzerland every year.
Biomedical research without boundaries
In autumn 2021 a new biomedical reseach centre will be inaugurated in Bellinzona. To support this event, Ticino Management is running a special series of articles presenting the activities of the two main residents of the facility, IRB and IOR.
In autumn 2021 a new biomedical reseach centre will be inaugurated in Bellinzona. To support this event, Ticino Management is running a special series of articles presenting the activities of the two main residents of the facility, IRB and IOR.
Roche purchases shares in tender offer for GenMark Diagnostics, Inc
Basel, 22 April 2021 - Roche and GenMark Diagnostics, Inc. today announced that Roche's wholly owned subsidiary Geronimo Acquisition Corp.
Basel, 22 April 2021 - Roche and GenMark Diagnostics, Inc. today announced that Roche's wholly owned subsidiary Geronimo Acquisition Corp.
EPFL spin-off Readily3D has developed a novel system that can print biological tissue in just 30 seconds.
The end of the pandemic is still not in sight, but we have every reason to be hopeful. How has the first year of living with the virus changed ETH? And what will endure after the crisis ends? I only briefly experienced what ETH was like before the pandemic.
Bad news for allergy sufferers: The rising temperatures over the past three decades have impacted the onset, duration and intensity of the pollen season in Switzerland. These are the results of a study by the Swiss Tropical and Public Health Institute (Swiss TPH) in collaboration with the Federal Office of Meteorology and Climatology (MeteoSwiss).
A team of researchers from the Institute for Infectious Diseases (IFIK) at the University of Bern and the Federal Institute of Virology and Immunology (IVI) have assessed virus growth and activation
Roche launches Elecsys Epstein-Barr Virus (EBV) immunoassay panel to improve EBV infection staging
The Elecsys EBV panel accurately identifies the EBV infection stage from a single blood sample, which means less confirmatory testing and, potentially, faster diagnosis for patients Clear and quick d
The Elecsys EBV panel accurately identifies the EBV infection stage from a single blood sample, which means less confirmatory testing and, potentially, faster diagnosis for patients Clear and quick d
Making more targeted use of digital technologies, advancing industrial projects with the new OST Ostschweizer Fachhochschule (Eastern Switzerland University of Applied Sciences) and building a bridge to basic research thanks to Empa in St. Gallen.
A trial aiming to find a better treatment for multidrug-resistant tuberculosis (MDR-TB) has stopped enrolling patients early after its independent data safety and monitoring board indicated that the regimen being studied is superior to current care, and that more patient data was extremely unlikely to change the trial's outcome.
Novartis announces positive result of phase III study with radioligand therapy 177Lu-PSMA-617 in patients with advanced prostate cancer
Phase III VISION study with 177 Lu-PSMA-617 met both primary endpoints, significantly improving overall survival (OS) and radiographic progression-free survival (rPFS) in patients with PSMA-positive
Phase III VISION study with 177 Lu-PSMA-617 met both primary endpoints, significantly improving overall survival (OS) and radiographic progression-free survival (rPFS) in patients with PSMA-positive
Evolution never stops - and disruptions can speed up the procees. Now ETH researchers are delving deeper into the secrets of evolutionary change.
